Insights

Minaris Regenerative Medicine’s leaders and experts are proud to share their knowledge and insight with the cell and gene therapy industry. Please review our current and past blog posts on topics of interest to this emerging industry.

    *This page may include mention of our past company names as it reflects content distributed in the past. The former companies Hitachi Chemical Advanced Therapeutics Solutions (HCATS, formerly PCT or PCT Cell Therapy Services), apceth Biopharma GmBH are all now operations under the name Minaris Regenerative Medicine. Hitachi Chemical Co., Ltd. has been renamed Showa Denko Materials Co., Ltd.
    July 16, 2019

    Improving Starting Material Stability for Cell Therapy Manufacturing

    The quality and consistency of starting material can have an enormous impact on downstream manufacturing processes in cell therapy. Recently, Hitachi Chemical partnered ...

    Read More
    July 5, 2018

    Demonstrating Scalable T-Cell Expansion in Stirred-Tank Bioreactors

    Cell therapy products have started to gain significant traction in the pharmaceutical industry in the last few years because of the potential they possess to treat many ...

    Read More
    January 29, 2018

    How Does Cryopreservation Affect Quality Control of Cell Therapies

    One of the major challenges of delivering a patient-specific cell therapy is that fresh cells for modification are usually only viable for about one to three days from ...

    Read More
    August 30, 2017

    Phase Appropriate Quality vs. Development by Design

    Developing a new cell therapy is a long and arduous process. Many cell therapies fail to clear all of the obstacles on the road to commercialization. When considering ...

    Read More
    July 9, 2015

    Defining your Cell Therapy: The Importance of a Quality Target Product Profile

    Before any cell therapy company can begin manufacturing a therapy, or designing and engineering the production equipment, it is necessary to engage in detailed ...

    Read More
    All Posts

    Subscribe to Our Email Distribution List
    © 2024 Minaris Regenerative Medicine   |  Privacy Policy   |  Imprint